GeneTex中国官方网站
  • China
癌症干细胞标记

癌症干细胞标记

Cell Cycle

Cancer stem cells (CSCs) are increasingly being recognized as the key determinative cells of malignancies. CSCs are described as relatively quiescent cells capable of self-renewal and the generation of more differentiated daughter cells that constitute the bulk of the tumor mass. While there is still debate as to the existence of a single subset of CSCs versus a collection of CSC variants in some tumors, a growing body of literature links CSCs to all steps of tumorigenesis, from initiation to metastasis. Even more ominously, however, evidence suggests that these cells are responsible for therapeutic resistance and relapse, with their persistence often meaning a poor clinical prognosis. For these reasons, CSC biology has become a vigorously studied area of cancer research.

Cancer Stem Cell Markers
Cell Cycle
See all related Products

 

热门研究产品
 

 

SOX2 antibody [GT1876] (GTX627404)

SOX2 antibody [GT1876],
C-term
(GTX627404)

ALDH1A1 antibody (GTX123973)

ALDH1A1 antibody
(GTX123973)

CD44 antibody [GT981] (GTX628472)

CD44 antibody [GT981]
(GTX628472)

IL3 Receptor alpha antibody [N2C2], Internal (GTX101563)

IL3 Receptor alpha antibody [N2C2], Internal
(GTX101563)

Integrin beta 1 / CD29 antibody (GTX128839)

Integrin beta 1 / CD29 antibody
(GTX128839)

Integrin beta 1 / CD29 antibody (GTX128839)

Bmi1 antibody
(GTX114008)

 
Literature

单页 - Cited Antibodies 2024 Q2

下载GeneTex最新版本的Cited Antibodies 2024 Q2单页
Promotion
六码一抗 不分包装~全面EXTRA 5% OFF!

六码一抗 不分包装~全面EXTRA 5% OFF!

Promotion

GeneTex重组抗体试用计划

Promotion

您发文献 我送奖励 | 2024文献奖励方案

Newsletter

Vimentin (波形蛋白) 在病毒感染过程中的角色

Vimentin是一种中间丝蛋白,在诸如细胞分裂和迁徙等基本的细胞生命活动过程中,扮演细胞骨架整合的关键功能...
Newsletter
用于Omicron研究的抗体和重组蛋白

用于Omicron研究的抗体和重组蛋白

WHO将SARS-CoV-2变体B.1.1.529指定为第五种关注变体(VOC),并将其命名为“Omicron”...
Newsletter
通过敲除验证的整合素 β-1抗体

通过敲除验证的整合素 β-1抗体

整合素是由α和β亚基组成的异二聚体蛋白,已在哺乳动物中发现了至少 18 个 α 亚基和 8 个 β 亚基...
Literature
小冊 - Cited Antibodies

小冊 - Cited Antibodies

下载 GeneTex 最新版本的 Cited Antibodies 小册
Articles
GeneTex 「5+1」 验证策略

GeneTex 「5+1」 验证策略

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter
GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组
Literature
Recombinant Active Proteins

折页 - 活性蛋白

下载 GeneTex 最新版本的活性蛋白折页
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Newsletter

「胶」你怎么做!Western blot省时小密技

Literature

单页 - Cited Antibodies 2024 Q2

下载GeneTex最新版本的Cited Antibodies 2024 Q2单页
Literature
小冊 - Cited Antibodies

小冊 - Cited Antibodies

下载 GeneTex 最新版本的 Cited Antibodies 小册
Literature
Recombinant Active Proteins

折页 - 活性蛋白

下载 GeneTex 最新版本的活性蛋白折页
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页